LINK MEDICAL RESEARCH AS
0283 OSLO
Return on Equity
7,42Â %
Current Ratio
0,77
Debt-to-Equity Ratio
0,93
Key figures (NOK) | 2022 | |
---|---|---|
Revenue | 77Â 709Â 000 | |
Net Income | 1Â 311Â 000 | |
Total Assets | 67Â 992Â 000 | |
Total Equity | 17Â 664Â 000 |
Income (NOK) | 2022 | |
---|---|---|
Revenue | 77Â 709Â 000 | |
Expenditure | 84Â 618Â 000 | |
Operating Profit | −6 910 000 | |
Financial Income | 8Â 106Â 000 | |
Financial Costs | 2Â 564Â 000 | |
Financial Balance | 5Â 542Â 000 | |
Earnings Before Tax | −1 367 000 | |
Tax | −2 679 000 | |
Net Income | 1Â 311Â 000 |
Balance (NOK) | 2022 | |
---|---|---|
Total Fixed Assets | 41Â 869Â 000 | |
Total Current Assets | 26Â 122Â 000 | |
Total Assets | 67Â 992Â 000 | |
Total Retained Equity | 13Â 264Â 000 | |
Total Equity | 17Â 664Â 000 | |
Total Long-Term Debt | 16Â 396Â 000 | |
Total Current Debt | 33Â 931Â 000 | |
Total Equity and Debt | 67Â 992Â 000 |
Cash flow (NOK) | 2022 | |
---|---|---|
Sales Income | 77Â 709Â 000 | |
Other Income | 0 | |
Revenue | 77Â 709Â 000 | |
Cost of Goods Sold | 11Â 602Â 000 | |
Salary Costs | 60Â 671Â 000 | |
Depreciation | 506Â 000 | |
Impairment | 0 | |
Expenditure | 84Â 618Â 000 | |
Operating Profit | −6 910 000 | |
Financial Income | 8Â 106Â 000 | |
Financial Costs | 2Â 564Â 000 | |
Financial Balance | 5Â 542Â 000 | |
Dividends | 0 | |
Net Income | 1Â 311Â 000 |
Balance details (NOK) | 2022 | |
---|---|---|
Goodwill | 0 | |
Total Intangible Assets | 5Â 913Â 000 | |
Real Eastate | 0 | |
Machinery and Plant Facilities | 0 | |
Fixtures | 449Â 000 | |
Total Tangible Assets | 488Â 000 | |
Total Fiancial Fixed Assets | 35Â 469Â 000 | |
Total Fixed Assets | 41Â 869Â 000 | |
Stock | 0 | |
Total Investments | 0 | |
Cash, Bank | 2Â 951Â 000 | |
Total Current Assets | 26Â 122Â 000 | |
Total Assets | 67Â 992Â 000 | |
Total Equity | 17Â 664Â 000 | |
Short-Term Group Debt | 13Â 348Â 000 | |
Total Long-Term Debt | 16Â 396Â 000 | |
Creditors | 1Â 311Â 000 | |
Unpaid Taxes | 5Â 784Â 000 | |
Dividends | 0 | |
Other Current Debt | 9Â 609Â 000 | |
Total Current Debt | 33Â 931Â 000 | |
Total Equity and Debt | 67Â 992Â 000 |
Financial indicators | 2022 | |
---|---|---|
Return on Equity | 7,42Â % | |
Debt-to-Equity Ratio | 0,93 | |
Operating Profit Margin | −8,89 % | |
Current Ratio | 0,77 | |
Quick Ratio | 0,77 | |
Equity Ratio | 0,26 | |
Gross Profit Margin | 85,07Â % |
Rotate your device to see the full table